NeuroOne is actively developing a full portfolio of products for use in intracranial electroencephalogram (iEEG) recordings and treatment. Our coming diagnostic products leverage a platform to offer far greater accuracy and specificity in recorded brain activity than is currently available. Future minimally invasive options and all-in-one devices for diagnosis and treatment are also in development.
Approximately one million U.S. patients with refractory epilepsy are left without treatment options between ineffective medication and highly invasive brain surgery1. NeuroOne technology aims to open the door to minimally invasive surgical diagnostic and treatment options for these patients. Our technology also has applications in related disorders including Parkinson’s Disease, Dystonia and Essential Tremors.
NeuroOne works with world class physicians and scientists at leading centers of excellence. Our current collaborators include the Mayo Clinic and Wisconsin Alumni Research Foundation (WARF) among others.